374 related articles for article (PubMed ID: 17627519)
1. Therapeutic targets in the ARF tumor suppressor pathway.
Saporita AJ; Maggi LB; Apicelli AJ; Weber JD
Curr Med Chem; 2007; 14(17):1815-27. PubMed ID: 17627519
[TBL] [Abstract][Full Text] [Related]
2. The flexible evolutionary anchorage-dependent Pardee's restriction point of mammalian cells: how its deregulation may lead to cancer.
David-Pfeuty T
Biochim Biophys Acta; 2006 Jan; 1765(1):38-66. PubMed ID: 16219425
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
4. The INK4a/ARF network in tumour suppression.
Sherr CJ
Nat Rev Mol Cell Biol; 2001 Oct; 2(10):731-7. PubMed ID: 11584300
[TBL] [Abstract][Full Text] [Related]
5. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of ARF regulation that control senescence and cancer.
Ko A; Han SY; Song J
BMB Rep; 2016 Nov; 49(11):598-606. PubMed ID: 27470213
[TBL] [Abstract][Full Text] [Related]
7. Polyoma virus disrupts ARF signaling to p53.
Lomax M; Fried M
Oncogene; 2001 Aug; 20(36):4951-60. PubMed ID: 11526480
[TBL] [Abstract][Full Text] [Related]
8. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
10. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
[TBL] [Abstract][Full Text] [Related]
11. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y; Xiong Y
Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
[TBL] [Abstract][Full Text] [Related]
12. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
[TBL] [Abstract][Full Text] [Related]
13. p53-independent functions of the p19(ARF) tumor suppressor.
Weber JD; Jeffers JR; Rehg JE; Randle DH; Lozano G; Roussel MF; Sherr CJ; Zambetti GP
Genes Dev; 2000 Sep; 14(18):2358-65. PubMed ID: 10995391
[TBL] [Abstract][Full Text] [Related]
14. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
15. MUC1 oncoprotein suppresses activation of the ARF-MDM2-p53 pathway.
Raina D; Ahmad R; Chen D; Kumar S; Kharbanda S; Kufe D
Cancer Biol Ther; 2008 Dec; 7(12):1959-67. PubMed ID: 18981727
[TBL] [Abstract][Full Text] [Related]
16. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
[TBL] [Abstract][Full Text] [Related]
17. ARF tumor suppression in the nucleolus.
Maggi LB; Winkeler CL; Miceli AP; Apicelli AJ; Brady SN; Kuchenreuther MJ; Weber JD
Biochim Biophys Acta; 2014 Jun; 1842(6):831-9. PubMed ID: 24525025
[TBL] [Abstract][Full Text] [Related]
18. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
19. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function.
David-Pfeuty T; Nouvian-Dooghe Y
Oncogene; 2002 Oct; 21(44):6779-90. PubMed ID: 12360404
[TBL] [Abstract][Full Text] [Related]
20. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]